State Secretary Blokhuis: boys will also be vaccinated against HPV virus
The vaccine against the HPV human papillomavirus virus will also become available for boys.
Antimicrobial resistance in the Netherlands is remaining reasonably stable
Antimicrobial resistance is increasing on a global level. It is difficult to treat infections caused by resistant bacteria.
Possible health risks due to exposure to chromium-6 at tROM project Tilburg
Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.
Research: HPV vaccine is safe
RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.
Vaccination rate again drops slightly, HPV vaccination rate drops considerably
The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.
CAESAR annual report 2014
The World Health Organization (WHO) published its first CAESAR annual report 2014.
RIVM and Olive Foundation open trading to mark the European Cervical Cancer Prevention Week
January 20th, the Olive Foundation and RIVM opened AEX trading day in Amsterdam on the occasion of the 9th European Cervical Cancer Prevention Week.
The National Immunisation Programme in the Netherlands 2013 - 2014
Every year, RIVM provides an overview of surveillance and developments in the National Immunisation Programme (NIP).